跳至主要内容
临床试验/JPRN-UMIN000006323
JPRN-UMIN000006323已完成2 期

Voriconazole (VRCZ) versus Itraconazole (ITCZ) for fungal prophylaxis in allogeneic hematopoietic stem cell transplantation (HSCT) patients with graft-versus-host disease (GVHD): A multicenter randomized trial - VRCZ vs ITCZ for fungal prophylaxis in GVHD patients

Grants from the Japanese Ministry of Health, Labor and Welfare0 个研究点目标入组 66 人开始时间: 2011年9月12日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
66

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients who had hypersensitivity against the study drugs. 2) Patients who received VRCZ or ITCZ within 7 days before registration. Patients who received antifungal drugs other than the study drugs (such as fluconazole and micafungin) can be registered if they discontinue the antifungal drugs before before registration. 3) Patients who had recurrent malignancies during the period from HSCT to registration. 4) Patients with chronic GVHD whose steroid dose was planed rapidly decreased within 3 weeks. 5) Patients who required medications that are contraindicated for the concurrent use of azoles.

研究者

发起方
Grants from the Japanese Ministry of Health, Labor and Welfare

相似试验